Skip to main content
Log in

Risk of acute upper gastrointestinal bleeding in patients with ulcerative disease and treatment with non-steroidal anti-inflammatory drugs (NSAIDs)

Results from the Comprehensive Hospital Drug Monitoring Berne (CHDM)

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The hospital prevalence rate for upper gastrointestinal ulcerative disease in 28,531 inpatients consecutively admitted in two teaching hospitals in the Comprehensive Hospital Drug Monitoring (CHDM) in Berne, from 1974 to 1985, was 2.2% (1.8% for gastric or duodenal ulcer, and 0.4% for erosive gastritis). This was based on the evaluation of 634 patients after exclusion of the subgroup of patients with hepatic cirrhosis or upper gastrointestinal neoplasia.

After exclusion of patients on anticoagulant therapy (n=73), 561 (=100%) patients could be further studied. Of them, 33.3% (n=187) were found to have been exposed to non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin, within 21 days prior to confirmation of the diagnosis.

The observed relative risk (RR) of developing a substantial acute upper gastrointestinal bleeding (Hb < 10 g/100 ml for men, and <9 g/100 ml for women, or a decrease in Hb of more than 25%) was 1.61 when patients exposed to NSAIDs (n=187) were compared to patients not exposed to those drugs (n=374). Although there was no significant sex difference overall, the RR for gastrointestinal bleeding differed considerably in the various age-groups; it was elevated in men under 40 years (RR=2.86) and in women over 60 years of age (RR=1.89), as compared to the mean RR of 1.61.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CHDM:

Comprehensive Hospital Drug Monitoring

GIB:

acute upper gastrointestinal bleeding

ICD:

International Classification of Diseases, 9 revision

NSAID:

non-steroidal anti-inflammatory drug

RR:

relative risk

References

  1. Carson JL, Strom BL, Soper KA, West SL, Morse ML (1987) The Association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med 147: 85–89

    Google Scholar 

  2. Coggon D, Lambert P, Langman MJS (1981) 20 years of hospital admissions for peptic ulcer in England and Wales. Lancet I: 1302–1304

    Google Scholar 

  3. Coggon D, Langman MJS, Spiegelhalter D (1982) Aspirin, paracetamol, and haematemesis and melaena. Gut 23: 340–344

    Google Scholar 

  4. Conn HO, Blitzer BL (1979) Nonassociation of adrenocorticosteroid therapy and peptic ulcer. N Engl J Med 294: 473–479

    Google Scholar 

  5. Duggan JM, Dobson AJ, Johnson H, Fahey P (1986) Peptic ulcer and non-steroidal anti-inflammatory agents. Gut 27: 929–933

    Google Scholar 

  6. Elashoff JD, Grossman MI (1980) Trends in hospital admissions and death rates for peptic ulcer in the united states from 1970 to 1978. Gastroenterology 78: 280–285

    Google Scholar 

  7. Eliakim R, Ophir M, Rachmilewitz D (1987) Duodenal mucosal injury with nonsteroidal antiinflammatory drugs. J Clin Gastroenterol 9: 395–399

    Google Scholar 

  8. Fleiss JL (1973) Statistical methods for rates and proportions. John Wiley and Sons, New York

    Google Scholar 

  9. Guess HA, West R, Strand LM, Helston D, Lydick EG, Bergman U, Wolski K (1988) Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983. J Clin Epidemiol 41: 35–45

    Google Scholar 

  10. Guslandi M (1988) How does smoking harm the duodenum? Br Med J 296: 311

    Google Scholar 

  11. Haefeli AM (1986) Beeinflussung der Häufigkeit akuter oberer gastrointestinaler Blutungen durch nicht-steroidale Antirheumatika bei Patienten mit peptischen Läsionen im gastro-duodenalen Bereich — Eine retrospektive Studie an 145 Fällen. Inaugural-Dissertation, Medizinische Fakultät der Universität Bern

  12. Harrison A, Elashoff J, Grossman MI (1979) Peptic ulcer disease in “Smoking and Health, a report of the Surgeon General (prepared by Agencies of the U.S. Department of Health, Education and welfare/National Institute of Arthritis, Metabolism, and Digestive Diseases)” pp 9–21

  13. Hoigné R, Hottinger S (1988) Monitoring adverse drug reactions in the postmarketing phase. Pharm Acta Helv 1: 2–12

    Google Scholar 

  14. Ivey KJ, Silvoso GR, Kruase WJ (1978) Effect of paracetamol on gastric mucosa. Br Med J 1: 1586–1588

    Google Scholar 

  15. Jick H (1981) Effects of Aspirin and Acetaminophen in gastrointestinal hemorrhage. Arch Intern Med 141: 316–321

    Google Scholar 

  16. Jick SS, Perera DR, Walker AM, Jick H (1987) Non-steroidal anti-inflammatory drugs and hospital admission for perforated peptic ulcer. Lancet II: 380–382

    Google Scholar 

  17. Kikendall JW, Evaul J, Johnson LF (1984) Effect of cigarette smoking on gastrointestinal physiology and non-neoplastic digestive disease. J Clin Gastroenterol 6: 65–78

    Google Scholar 

  18. Kurata JH, Haile BM, Elashoff JD (1985) Sex differences in peptic ulcer disease. Gastroenterology 88: 96–100

    Google Scholar 

  19. Langman MJS (1986) Anti-inflammatory drug intake and the risk of ulcer complications. Med Toxicol 1 [Suppl 1]: 34–38

    Google Scholar 

  20. Langman MJS (1987) The changing face of peptic ulceration. Scand J Gastroenterol 136: 37–40

    Google Scholar 

  21. Levy M (1974) Aspirin use in patients with major upper gastrointestinal bleeding and peptic-ulcer disease. N Engl J Med 290: 1158–1162

    Google Scholar 

  22. McCarthy DM (1984) Smoking and ulcers — time to quit. N Engl J Med 311: 726–728

    Google Scholar 

  23. Messer J, Reitman D, Sacks HS, Smith H, Chalmers T (1983) Association of adrenocorticosteroid therapy and peptic-ulcer disease. N Engl J Med 309: 21–24

    Google Scholar 

  24. Negre J (1985) Perforated ulcer in elderly people. Lancet II: 1118–1119

    Google Scholar 

  25. Piper DW, McIntosh JH, Ariotti DE, Fenton BH, Mac Lennan RM (1981) Analgesic ingestion and chronic peptic ulcer. Gastroenterology 80: 427–432

    Google Scholar 

  26. Scott JT, Porter IH, Lewis SM, Dixon StJ (1961) Studies of gastrointestinal bleeding caused by corticosteroids, salicylates and other analgesics. Q J Med XXX (NS) 118: 167–188

    Google Scholar 

  27. Singer MV (1986) Bewirken reiner Alkohol und alkoholische Getränke beim Menschen eine Stimulation der Magensäuresekretion und eine Freisetzung von Gastrin? Dtsch Med Wochenschr 111: 749–752

    Google Scholar 

  28. Somerville K, Faulkner G, Langman M (1986) Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet i: 462–464

    Google Scholar 

  29. Sonnenberg A, Fritsch A (1983) Changing mortality of peptic ulcer disease in Germany. Gastroenterology 84: 1553–1557

    Google Scholar 

  30. Walt R, Logan R, Katschinski B, Ashley J (1986) Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet I: 489–492

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stodolnik, E., Maurer, P., Hoigné, R. et al. Risk of acute upper gastrointestinal bleeding in patients with ulcerative disease and treatment with non-steroidal anti-inflammatory drugs (NSAIDs). Eur J Clin Pharmacol 38, 31–35 (1990). https://doi.org/10.1007/BF00314799

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00314799

Key words

Navigation